FreeGuest Editorial A long road ahead but every reason to travel with purpose October 09, 2020Vol.46 No.38By Roy A. Jensen and Karen E. Knudsen
Free First-ever TCL-AACI study of the leadership pipeline points to urgent need for more diversity at elite cancer centers October 09, 2020Vol.46 No.38By Matthew Bin Han Ong and Katie Goldberg
Free Sexual harassment reporting structures in oncology are broken, The Cancer Letter survey finds October 02, 2020Vol.46 No.37By Alexandria Carolan, Katie Goldberg and Matthew Bin Han Ong
FreeTrials & Tribulations The cancer detection rate—a public health approach to early detection October 02, 2020Vol.46 No.37By Joshua J. Ofman and Azra Raza
Conversation with The Cancer LetterFree Leonidas Platanias: These incidents are “really shocking and disturbing” October 02, 2020Vol.46 No.37By Alexandria Carolan
Conversation with The Cancer LetterFree Pamela Kunz: “In any other industry, if someone had behavior like that, they would be fired.” October 02, 2020Vol.46 No.37By Alexandria Carolan
Free In their own words: Responses to The Cancer Letter survey on gender bias October 02, 2020Vol.46 No.37
Free AACR report: COVID struck as science was making unprecedented impact on cancer September 25, 2020Vol.46 No.36By Alexandria Carolan
Conversation with The Cancer Letter Vincent Vinciguerra receives NCORP 2020 Harry Hynes Award September 25, 2020Vol.46 No.36By Paul Goldberg
Real-world Evidence Study of NSCLC, melanoma outcomes points to surrogacy between real-world endpoints and clinical trial endpoints September 25, 2020Vol.46 No.36By Matthew Bin Han Ong
